STOCK TITAN

Oculis Publishes Notification of Transactions by Person Discharging Managerial Responsibilities

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Oculis (NASDAQ:OCS) has announced that a Person Discharging Managerial Responsibilities (PDMR) has executed trades in accordance with a pre-established Rule 10b5-1 trading plan. The transactions were conducted under the Securities Exchange Act of 1934 guidelines, demonstrating compliance with regulatory requirements for insider trading.

Oculis (NASDAQ:OCS) ha comunicato che una persona con responsabilità dirigenziali (PDMR) ha effettuato operazioni secondo un predefinito piano di trading Rule 10b5-1. Le transazioni sono state eseguite in conformità alle direttive del Securities Exchange Act del 1934, dimostrando il rispetto dei requisiti normativi sull insider trading.

Oculis (NASDAQ:OCS) ha anunciado que una Persona con Responsabilidades Directivas (PDMR) ha ejecutado operaciones de acuerdo con un plan de negociación preestablecido Rule 10b5-1. Las transacciones se realizaron conforme a las directrices de la Ley de Intercambio de Valores de 1934, evidenciando el cumplimiento de los requisitos regulatorios para el trading de información privilegiada.

Oculis (NASDAQ:OCS)은 관리 책임을 가진 사람(PDMR)이 사전에 확정된 Rule 10b5-1 거래 계획에 따라 거래를 실행했다고 발표했습니다. 이 거래는 1934년 증권거래법의 가이드라인에 따라 수행되어 내부자 거래에 대한 규제 요건의 соблю를 보여줍니다.

Oculis (NASDAQ:OCS) a annoncé qu'une Personne exerçant des responsabilités managériales (PDMR) a exécuté des transactions conformément à un plan de trading Rule 10b5-1 préétabli. Les opérations ont été réalisées selon les directives du Securities Exchange Act de 1934, démontrant le respect des exigences réglementaires relatives au trading d’informations privilégiées.

Oculis (NASDAQ:OCS) hat bekannt gegeben, dass eine Person mit geschäftsführenden Verantwortlichkeiten (PDMR) Trades gemäß einem vorab festgelegten Rule 10b5-1 Handelsplan durchgeführt hat. Die Transaktionen erfolgten im Einklang mit den Richtlinien des Securities Exchange Act von 1934 und zeigen die Einhaltung der regulatorischen Anforderungen für Insiderhandel.

Oculis (NASDAQ:OCS) أعلنت أن فرداً يشغل مسؤوليات إدارية (PDMR) نفّذ صفقات وفق خطة تداول Rule 10b5-1 محددة سلفاً. جاءت المعاملات وفقاً لإرشادات قانون تبادل الأوراق المالية لعام 1934، مما يعكس الالتزام بالمتطلبات التنظيمية للتعامل بناءً على معلومات داخلية.

Oculis (NASDAQ:OCS)宣布,一名履行管理职责的人员(PDMR)已按照预先设定的Rule 10b5-1 交易计划执行交易。该等交易遵循1934年《证券交易法》的指引,表明符合内幕交易的监管要求。

Positive
  • None.
Negative
  • None.

ZUG, Switzerland, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to trades entered into by a PDMR of the Company pursuant to a 10b5-1 trading plan, in accordance with Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended.

Attachment


FAQ

What type of transaction did Oculis (OCS) announce on September 26, 2025?

Oculis announced trades executed by a PDMR (Person Discharging Managerial Responsibilities) under a pre-established Rule 10b5-1 trading plan.

What is a Rule 10b5-1 trading plan for Oculis stock?

A Rule 10b5-1 trading plan is a pre-arranged trading schedule that allows company insiders to trade company stock according to predetermined parameters while complying with insider trading regulations.

Why do Oculis executives use 10b5-1 trading plans?

Executives use these plans to trade company shares in a compliant manner while avoiding accusations of insider trading, as trades are scheduled in advance when they don't possess material non-public information.

How does Oculis ensure compliance with insider trading regulations?

Oculis ensures compliance by having insiders execute trades through pre-established 10b5-1 trading plans in accordance with the Securities Exchange Act of 1934 requirements.
Oculis Holding

NASDAQ:OCS

OCS Rankings

OCS Latest News

OCS Latest SEC Filings

OCS Stock Data

915.88M
49.03M
6.31%
31.25%
0.02%
Biotechnology
Healthcare
Link
Switzerland
Zug